Wearable Technologies (Jan 2023)

Instrumented insoles for assessment of gait in patients with vestibular schwannoma

  • Stephen Leong,
  • Bing M. Teh,
  • Ton Duong,
  • Diane Hu,
  • Alexander Chui,
  • Jocelyn S. Chen,
  • Michael B. Sisti,
  • Tony J.C. Wang,
  • Damiano Zanotto,
  • Anil K. Lalwani

DOI
https://doi.org/10.1017/wtc.2023.11
Journal volume & issue
Vol. 4

Abstract

Read online

Abstract Background Imbalance and gait disturbances are common in patients with vestibular schwannoma (VS) and can result in significant morbidity. Current methods for quantitative gait analysis are cumbersome and difficult to implement. Here, we use custom-engineered instrumented insoles to evaluate the gait of patients diagnosed with VS. Methods Twenty patients with VS were recruited from otology, neurosurgery, and radiation oncology clinics at a tertiary referral center. Functional gait assessment (FGA), 2-minute walk test (2MWT), and uneven surface walk test (USWT) were performed. Custom-engineered instrumented insoles, equipped with an 8-cell force sensitive resistor (FSR) and a 9-degree-of-freedom inertial measurement unit (IMU), were used to collect stride-by-stride spatiotemporal gait parameters, from which mean values and coefficients of variation (CV) were determined for each patient. Results FGA scores were significantly correlated with gait metrics obtained from the 2MWT and USWT, including stride length, stride velocity, normalized stride length, normalized stride velocity, stride length CV, and stride velocity CV. Tumor diameter was negatively associated with stride time and swing time on the 2MWT; no such association existed between tumor diameter and FGA or DHI. Conclusions Instrumented insoles may unveil associations between VS tumor size and gait dysfunction that cannot be captured by standardized clinical assessments and self-reported questionnaires.

Keywords